Transcatheter Aortic Valve Replacement News and Research

RSS

Transcatheter cerebral embolic protection effectively captures embolic debris and safe in TAVR patients

An international study has found that transcatheter cerebral embolic protection (TCEP) is safe, provides effective capture of embolic debris and does not change neurocognitive function for transcatheter aortic valve replacement (TAVR) patients.

2 Nov 2016

Researchers develop new, less invasive method to perform TAVR for treating aortic valve stenosis

Researchers at the National Institutes of Health have developed a new, less invasive way to perform transcatheter aortic valve replacement (TAVR), a procedure widely used to treat aortic valve stenosis, a lethal heart condition.

31 Oct 2016

Zeus introduces new MRI-compatible LCP monofilament for vascular interventions

Magnetic resonance imaging (MRI) uses a strong magnetic field to image the body and is known as the gold standard in diagnostic imaging.

From Zeus Inc. 15 Sep 2016

Study reveals risk factors and outcomes of infective endocarditis after TAVR

Among patients undergoing transcatheter aortic valve replacement, younger age, male sex, history of diabetes mellitus, and moderate to severe residual aortic regurgitation were significantly associated with an increased risk of infective endocarditis, and patients who developed endocarditis had high rates of in-hospital mortality and 2-year mortality, according to a study appearing in the September 13 issue of JAMA.

13 Sep 2016

Simplified approach to TAVI holds potential to save lives of many patients with rheumatic heart disease

A novel heart valve replacement method is revealed today that offers hope for the thousands of patients with rheumatic heart disease who need the procedure each year. The research is being presented at the SA Heart Congress 2016

9 Sep 2016

SAPIEN 3 trans-catheter aortic valve replacement system improves survival in patients with aortic stenosis

Overall one-year survival was over 85 percent for high-risk or inoperable patients who underwent aortic valve replacement with the SAPIEN 3 trans-catheter aortic valve replacement system, according to a study published in the July 12 issue of the American Heart Association journal Circulation.

29 Jul 2016

Essential Medical receives CE Mark approval for novel vascular closure device

Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has received CE Mark approval for MANTA, the company's Large Bore Vascular Closure Device.

18 Jul 2016

Clinical study examines new treatment option for aortic stenosis patients with larger valve structure

A clinical trial exploring a new minimally invasive treatment option for some patients with severe aortic stenosis recently launched at Baylor Jack and Jane Hamilton Heart and Vascular Hospital.

14 Jul 2016

UTHealth researchers examine effectiveness of Sapien 3 TAVR in low-risk patients with aortic stenosis

The Structural Heart Program team at McGovern Medical School at The University of Texas Health Science Center at Houston is among the first in the country to investigate the safety and effectiveness of Edwards Lifesciences Sapien 3 transcatheter aortic heart valve in low surgical risk patients who suffer from severe aortic valve disease.

8 Jul 2016

Unseen health risks of aortic stenosis: an interview with Dr Shelley Rahman Haley

Aortic stenosis means narrowing of the aortic valve, which is the out flow valve from the left ventricle, the pumping chamber of the heart. This is the valve which opens to allow blood to flood out of the heart and all-round the body.

22 Jun 2016

Persistent low flow warns of mortality risk after TAVR

Patients with persistent low flow at discharge after transcatheter aortic valve replacement have an increased risk of dying during the subsequent year, report researchers.

21 Jun 2016

Penn researchers explore possibilities to improve outcomes in low flow AS patients treated with TAVR

Aortic stenosis (AS), the narrowing of the aortic valve in the heart which causes restricted blood flow, is one of the most common and serious valve disease problems. For patients with one type of AS - low flow - transcatheter aortic valve replacement (TAVR), a minimally invasive procedure which corrects the damaged aortic valve, is often the best option for restoring the heart's normal pumping function.

16 Jun 2016

Study shows women undergoing TAVR have longer-term survival rate compared to men

Data from one of the largest national registries of transcatheter aortic valve replacement (TAVR) patients shows that although women are more likely to experience vascular complications in the hospital, their one-year survival rate is more favorable than men.

10 May 2016

Moderate sedation leads to better clinical outcomes than general anesthesia for TAVR patients

A new study finds the use of moderate sedation, in which patients do not need a breathing tube, leads to better clinical outcomes as compared to general anesthesia for patients undergoing transcatheter aortic valve replacement (TAVR).

9 May 2016

Study finds no gender-based differences on use of anticoagulation medications in TAVR patients

A study on the impact of using different anticoagulation medications on men and women who have undergone a transcatheter aortic valve replacement (TAVR) found no difference in early vascular complications or mortality.

9 May 2016

TAVR procedure could provide improved health outcomes for inoperable patients

A novel procedure for heart valve replacement surgery could provide improved health outcomes for patients who cannot have open heart surgery, as well as being a cost effective alternative.

22 Apr 2016

Study evaluates long-term outcomes of TAVR with SAPIEN 3 in intermediate-risk patients

To account for baseline differences, TAVR patients were compared by a propensity score analysis with patients randomized to receive surgical intervention in a precursor study, PARTNER 2A. Propensity scoring analysis is a statistical technique used to reduce bias from potential confounding variables, which in this case was used to identify surgical patients from a previous study who would be comparable to TAVR patients in this study.

4 Apr 2016

Frequent TAVR to replace damaged aortic heart valve improves patient outcomes

The more frequently a hospital performs a minimally invasive technique called transcatheter aortic valve replacement, or TAVR, to replace a damaged aortic heart valve, the better patients fare, on average, immediately after the procedure, researchers reported at the American College of Cardiology's 65th Annual Scientific Session.

4 Apr 2016

New BayCare Cardiovascular and Thoracic Surgery office opens at St. Anthony's Hospital

To improve access to high-quality, advanced cardiac surgery services in St. Petersburg and south Pinellas County, BayCare Health System has opened a BayCare Cardiovascular and Thoracic Surgery office at St. Anthony's Hospital.

24 Feb 2016

Edwards Lifesciences' global sales grow 8.6% to $671.1 million in fourth quarter 2015

Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended December 31, 2015.

3 Feb 2016